Use of regression analysis and flow cytometry for determining levels of mixed semiallogeneic immune chimerism

Journal of Investigative Surgery

Volumn 9, Issue 4, 1996, Pages 273-281

  Ramsamooj, Rajen ^a   Patel, Mayuri P ^a   Llull, Ramon ^a,b,c   Levin, Steven ^a   Black, Kirby S ^a,d   Hewitt, Charles W ^a,e  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BARCELONA   (Spain)

^d CRYOLIFE INC   (United States)

^e Department of Anesthesiology   (United States)

Author keywords

Bone marrow transplantation; Chimerism; Composite tissue allografts (hind limb); GVHD; Tolerance

Indexed keywords

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; CHIMERA; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT SURVIVAL; IMMUNOFLUORESCENCE TEST; LYMPHOCYTE; LYMPHOID CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REGRESSION ANALYSIS; SKIN ALLOGRAFT;

EID: 0029812344     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.3109/08941939609012477     Document Type: Article

References (25)

1. Ilstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature. 1984;307:168.
2. Thomas JM, Carver FM, Kasten-Jolly J, et al. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation. 1994;57:101.
3. Verbanac KM, Carver FM, Haisch CE, Thomas JM. A role for transforming growth factor-beta in the veto mechanism in transplant tolerance. Transplantation. 1994;57:893.
4. Hewitt CW, Black KS, Dowdy SF, et al. Composite tissue (limb) allografts in rats, III: development of donor-host lymphoid chimeras in long-term survivors. Transplantation. 1986;41:39.
5. Henson LE, Hewitt CW, Black KS. Use of regression analysis and the complement-dependent cytotoxicity typing assay for predicting lymphoid chimerism. J Immunol Methods. 1988;114:139.
6. Hewitt CW, Black KS, Henson LE, Achauer BM, Nguyen JHT. Lymphocyte chimerism in a full allogeneic composite tissue (rat-limb) allograft model prolonged with cyclosporine. Transplant Proc. 1988;20:272.
7. Dorsch S, Roser B. Suppressor cells in transplantation tolerance, II: identification and probable mode of action of chimeric suppressor T cells. Transplantation. 1982;33:525.
8. Ildstad ST, Bluestone JA, Sachs DH. Alloresistance to engraftment of allogeneic donor bone marrow is mediated by an Lyt-2+ T cell in mixed allogeneic reconstitution. J Exp Med. 1986;163:1343.
9. Petz L, Yam P, Wallace RB, et al. Mixed hemopoietic chimerism following bone marrow transplantation for hematologic malignancies. Blood. 1987;70:1331.
10. Pierce GE, Watts LM. The role of donor lymphoid cells in the transfer of allograft tolerance. Transplantation. 1985;40:702.
11. Sykes M, Eisenthal A, Sachs DH. Mechanism of protection from graft-versus-host disease in murine mixed allogeneic chimeras, I: development of a null cell population suppressive of cell-mediated lymphocytic responses and derived from the syngeneic bone marrow component. J Immunol. 1988;140:2903.
12. Hewitt CW, Ramsamooj R, Patel MP, Yazdi B, Achauer BM, Black KS. Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow transplantation. Transplantation. 1990;50:766.
13. Llull R, Ramsamooj R, Black KS, Hewitt CW. Cellular mechanisms of alloimmune nonresponsiveness in tolerant mixed lymphocyte chimeras induced by vascularized bone marrow transplants. Transplant Int. 1994;7:S453.
14. Hewitt CW, Black KS, Henson LE, Dowdy SF, Philosophe B, Martin DC. Serologic properties of the triple antibody-sandwich-agglutination assay (TASLA). J Clin Lab Immunol. 1989;28:45.
15. Hewitt CW, Sawyer S, Beck PA, Martin DC. A simple method for the isolation of platelet free lymphocyte suspensions from rat whole blood. J Immunol Methods. 1980;36:227.
16. Sokal RR, Rohlf FJ. In: Biometry. San Francisco: W.H. Freeman; 1969:454-477.
17. Blume KG, Beutler E, Bross KJ, Schmidt GM, Sprice WE, Teplitz RL. Genetic markers in human bone marrow transplantation. Am J Hum Genet. 1980;32:414.
18. Renherz EL, Geha R, Rappeport JM, et al. Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-missmatched bone marrow for severe combined immunodeficiency. Proc Natl Acad Sci USA. 1982;79:6047.
19. Witherspoon RP, Schanfield MS, Storb R, Thomas ED, Giblett ER. Immunoglobulin production of donor origin after bone marrow transplantation for acute leukemia or aplastic anemia. Transplantation. 1978;26:407.
20. Ginsburg D, Antin JH, Smith BR, Orkin SH, Rappaport JM. Analysis using DNA sequence polymorphisms. J Clin Invest. 1985;114:139.
21. Minden MD, Messner HA, Belch A. Origin of leukemic relapse after bone marrow transplantation detected by restriction fragment length polymorphism. J Clin Invest. 1985;75:91.
22. Korver K, de Lange GG, van der Bergh RL, et al. Lymphoid chimerism after allogenic bone marrow transplantation: Y-chromatin staining of peripheral T and B lymphocytes and allotyping of serum antiglobulins. Transplantation. 1987;44:643.
23. Boyse EA, Carswell EA, Sheid MP, Old LJ. Tolerance of Sk-incompatible skin grafts. Nature. 1973;244:441.
24. Krown SE, Coico R, Scheid MP, Fernandes G, Good RA. Immune function in fully allogeneic mouse bone marrow chimeras. Clin Immunol Immunopathol. 1981;19:268.
25. Norin AJ, Emeson EE, Veith FJ. Long-term survival of murine allogeneic bone marrow chimeras: effect of antilymphocyte serum and bone marrow dose. J Immunol. 1981;126:428.